chr9-96383501-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_007001.3(SLC35D2):āc.134A>Gā(p.Asn45Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000208 in 1,537,102 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 31)
Exomes š: 0.000021 ( 1 hom. )
Consequence
SLC35D2
NM_007001.3 missense
NM_007001.3 missense
Scores
6
10
3
Clinical Significance
Conservation
PhyloP100: 3.35
Genes affected
SLC35D2 (HGNC:20799): (solute carrier family 35 member D2) Nucleotide sugars, which are synthesized in the cytosol or the nucleus, are high-energy donor substrates for glycosyltransferases located in the lumen of the endoplasmic reticulum and Golgi apparatus. Translocation of nucleotide sugars from the cytosol into the lumen compartment is mediated by specific nucleotide sugar transporters, such as SLC35D2 (Suda et al., 2004 [PubMed 15082721]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.935
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC35D2 | NM_007001.3 | c.134A>G | p.Asn45Ser | missense_variant | 1/12 | ENST00000253270.13 | NP_008932.2 | |
SLC35D2 | NM_001286990.2 | c.134A>G | p.Asn45Ser | missense_variant | 1/9 | NP_001273919.1 | ||
SLC35D2 | NR_104627.2 | n.211A>G | non_coding_transcript_exon_variant | 1/13 | ||||
SLC35D2-HSD17B3 | NR_182427.1 | n.211A>G | non_coding_transcript_exon_variant | 1/26 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC35D2 | ENST00000253270.13 | c.134A>G | p.Asn45Ser | missense_variant | 1/12 | 1 | NM_007001.3 | ENSP00000253270.7 | ||
SLC35D2 | ENST00000375259.9 | c.134A>G | p.Asn45Ser | missense_variant | 1/9 | 1 | ENSP00000364408.4 | |||
SLC35D2 | ENST00000375257.2 | c.134A>G | p.Asn45Ser | missense_variant | 1/6 | 2 | ENSP00000364406.1 | |||
SLC35D2 | ENST00000482643.2 | n.180A>G | non_coding_transcript_exon_variant | 1/9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151914Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
3
AN:
151914
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000293 AC: 4AN: 136718Hom.: 1 AF XY: 0.0000401 AC XY: 3AN XY: 74752
GnomAD3 exomes
AF:
AC:
4
AN:
136718
Hom.:
AF XY:
AC XY:
3
AN XY:
74752
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000209 AC: 29AN: 1385188Hom.: 1 Cov.: 31 AF XY: 0.0000234 AC XY: 16AN XY: 683924
GnomAD4 exome
AF:
AC:
29
AN:
1385188
Hom.:
Cov.:
31
AF XY:
AC XY:
16
AN XY:
683924
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151914Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74218
GnomAD4 genome
AF:
AC:
3
AN:
151914
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74218
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | The c.134A>G (p.N45S) alteration is located in exon 1 (coding exon 1) of the SLC35D2 gene. This alteration results from a A to G substitution at nucleotide position 134, causing the asparagine (N) at amino acid position 45 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M;M;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;D;D
Vest4
MutPred
Gain of glycosylation at N45 (P = 0.0625);Gain of glycosylation at N45 (P = 0.0625);Gain of glycosylation at N45 (P = 0.0625);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at